News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
AOL.com Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
An officer at Rhythm Pharmaceuticals (RYTM.US) recently sold a substantial amount of common stock, totaling US$8.9 million. This transaction indicates a significant insider sale for the company.
Markel Group Inc. significantly increased its stake in Weyerhaeuser Company by 585.7% in the second quarter, now holding 120,000 shares valued at $2,873,000. Other institutional investors also adjusted their holdings in Weyerhaeuser, which saw its stock trading down slightly at $24.55. The company recently …
Levin Capital Strategies L.P. has acquired a new stake of 94,000 shares, valued at $2.25 million, in Weyerhaeuser Company (NYSE:WY) during the second quarter. Other institutional investors have also adjusted their holdings in the company. Wall Street analysts currently have a "Moderate Buy" rating …
Pictet Asset Management Holding SA reduced its stake in Weyerhaeuser Company (NYSE:WY) by 11.8% in the second quarter, selling 570,173 shares, but still holds 4.28 million shares valued at over $102 million. Analysts maintain a "Moderate Buy" rating for Weyerhaeuser with an average price …
NewEdge Advisors LLC significantly increased its stake in Weyerhaeuser Company (NYSE:WY) by 317.4% in the first quarter, now holding 89,800 shares valued at $2.19 million. Institutional investors collectively own a substantial 82.99% of the company. Weyerhaeuser reported strong Q1 earnings, surpassing analyst estimates with …
Cambiar Investors LLC increased its stake in Weyerhaeuser Company (NYSE:WY) by 5.3% in the second quarter, acquiring an additional 55,769 shares. This brings their total holdings to 1.10 million shares, valued at approximately $26.3 million. Weyerhaeuser also reported beating quarterly earnings expectations with adjusted …
Handelsbanken Fonder AB reduced its stake in Weyerhaeuser Company (NYSE:WY) by 17.9% in the second quarter, selling 48,885 shares and retaining 223,900 shares valued at $5.36 million. Despite the reduction, institutional investors collectively own 82.99% of Weyerhaeuser. The company reported strong quarterly earnings, beating …
Aberdeen Group plc increased its stake in Weyerhaeuser Company (NYSE:WY) by 13.8% in the second quarter, purchasing an additional 125,264 shares, bringing its total holdings to over 1 million shares valued at $24.7 million. Weyerhaeuser maintains a "Moderate Buy" consensus rating with an average …
AIA Group Ltd significantly increased its stake in Weyerhaeuser Company (NYSE:WY) by 92.4% in the second quarter, acquiring an additional 343,414 shares, bringing its total to 714,991 shares valued at $17.1 million. The article notes that institutional investors own a substantial 82.99% of WY …
This article from Stock Traders Daily discusses liquidity mapping around price events for Rhinebeck Bancorp Inc. (NASDAQ: RBKB). It highlights a near-term strong sentiment influencing mid-term neutrality toward a long-term positive bias, despite elevated downside risk. The analysis provides specific trading strategies (Position, Momentum …
Rhinebeck Bancorp has terminated its Executive Long-Term Incentive and Retention Plan, resulting in the full vesting of accounts for participants Jamie Bloom and Kevin Nihill, effective May 19, 2026. Both individuals were named executive officers and participants in the previously established plan. This change …
Weyerhaeuser Co (WY) is scheduled to go ex-dividend on September 4th, 2026, with a dividend payment of $0.21 per share. Investors wishing to receive this dividend must own shares before the ex-dividend date.
Jennifer Lee, EVP of Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM), sold approximately $8.9 million worth of common stock after exercising options for about $997,036. The sale was executed under a Rule 10b5-1 trading plan as the stock trades near its 52-week high and is considered overvalued …
Jennifer Kayden Lee, EVP of Rhythm Pharmaceuticals (RYTM), exercised 56,601 stock options at prices of $24.29 and $6.80, and subsequently sold 75,834 common shares at $117.3818 per share. These transactions, valued at approximately $8.90 million gross proceeds from sales and $997K in exercise costs, …
Algorhythm Holdings (NASDAQ: MICS) reported a net loss of $4.1 million for Q2 2026, or $0.25 per share, an increase from the $0.24 loss per share in Q2 2025, due to heavy investment in growth. Despite the widening loss, revenue surged by 161% to …
Weyerhaeuser Co. (WY) shares fell 1.05% on Friday, closing at $24.56, despite a broader market decline for the S&P 500 and Dow Jones Industrial Average. The stock is now 11.50% below its 52-week high of $27.75, which was reached on February 12th.
Rhinebeck Bancorp (RBKB) announced the termination of its Rhinebeck Bank Executive Long-Term Incentive and Retention Plan, a non-qualified deferred compensation plan, on May 19, 2026. The termination resulted in the immediate vesting of account balances for participating officers, including Jamie Bloom and Kevin Nihill. …
iRhythm Holdings,Inc. IRTC recently announced that it will acquire Vital Connect, Inc., a leader in wearable biosensor technology and ambulatory cardiac monitoring. The transaction is expected to expand iRhythm's addressable market and accelerate its evolution from ambulatory cardiac monitoring into a broader cardiac monitoring …
Algorhythm Holdings Inc has released its earnings summary for the quarter that ended on June 30. The article, sourced from Reuters and republished on TradingView News, provides an overview of the company's financial performance during this period. Readers can access the full report and …
Algorhythm Holdings (NASDAQ: RIME) reported Q2 2026 EPS of $(0.25), significantly beating the $(0.36) analyst consensus. Revenue reached $3.005 million, exceeding estimates by 0.17% and representing a 161% year-over-year increase, driven by strategic expansions in North America and India. Despite top-line growth, the company's …
Swiss Life Asset Management Ltd increased its stake in Weyerhaeuser Company (NYSE:WY) by 22.5% in the second quarter, bringing its total holdings to 231,651 shares valued at approximately $5.55 million. Weyerhaeuser reported earnings of $0.13 per share, beating estimates, though revenue decreased year-over-year. Analysts …
Algorhythm Holdings, Inc. (RIME) reported its Q2 2026 financial results, with revenue increasing to $3.01 million and a net loss of $(3.83) million, resulting in a diluted loss per share of $(0.25). This growth was largely due to the acquisition of SMCB and the …
Search by ticker symbol or company name and select a result to open its chart.